Senseonics Holdings Inc (NYSEAMERICAN:SENS) saw an uptick in trading volume on Thursday . 4,984,240 shares traded hands during trading, an increase of 261% from the previous session’s volume of 1,381,590 shares.The stock last traded at $2.68 and had previously closed at $2.38.
A number of research firms have recently commented on SENS. UBS Group began coverage on Senseonics in a report on Tuesday, November 27th. They set a “sell” rating for the company. Zacks Investment Research downgraded Senseonics from a “hold” rating to a “sell” rating in a report on Wednesday, February 6th. Finally, Piper Jaffray Companies began coverage on Senseonics in a report on Tuesday, January 29th. They set a “neutral” rating for the company. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $6.00.
A number of hedge funds and other institutional investors have recently made changes to their positions in SENS. BlackRock Inc. increased its holdings in Senseonics by 1,958.6% in the 2nd quarter. BlackRock Inc. now owns 3,811,007 shares of the company’s stock valued at $15,664,000 after purchasing an additional 3,625,877 shares in the last quarter. Massachusetts Financial Services Co. MA acquired a new stake in Senseonics in the 3rd quarter valued at $14,703,000. Janus Henderson Group PLC acquired a new stake in shares of Senseonics during the third quarter valued at about $12,222,000. Allianz Asset Management GmbH acquired a new stake in shares of Senseonics during the third quarter valued at about $4,308,000. Finally, Point72 Asset Management L.P. acquired a new stake in shares of Senseonics during the third quarter valued at about $3,944,000. Hedge funds and other institutional investors own 30.66% of the company’s stock.
WARNING: “Senseonics (SENS) Sees Large Volume Increase” was originally reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at https://www.chaffeybreeze.com/2019/02/21/senseonics-sens-sees-large-volume-increase.html.
Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.
Featured Story: Return on Investment (ROI) Defined, Explained
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.